103 related articles for article (PubMed ID: 12711203)
1. Optimization of extraction parameters for the chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets.
Gimeno P; Besacier F; Chaudron-Thozet H
Forensic Sci Int; 2003 Apr; 132(3):182-94. PubMed ID: 12711203
[TBL] [Abstract][Full Text] [Related]
2. A contribution to the chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets.
Gimeno P; Besacier F; Chaudron-Thozet H; Girard J; Lamotte A
Forensic Sci Int; 2002 Jun; 127(1-2):1-44. PubMed ID: 12098525
[TBL] [Abstract][Full Text] [Related]
3. Development of microwave-assisted extraction procedure for organic impurity profiling of seized 3,4-methylenedioxymethamphetamine (MDMA).
Giebink PJ; Smith RW
J Forensic Sci; 2011 Nov; 56(6):1483-92. PubMed ID: 21790601
[TBL] [Abstract][Full Text] [Related]
4. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong.
Cheng WC; Poon NL; Chan MF
J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267
[TBL] [Abstract][Full Text] [Related]
5. Development of a high-speed MALDI-triple quadrupole mass spectrometric method for the determination of 3,4-methylenedioxymethamphetamine (MDMA) in oral fluid.
Poetzsch M; Steuer AE; Hysek CM; Liechti ME; Kraemer T
Drug Test Anal; 2016 Feb; 8(2):235-40. PubMed ID: 25990956
[TBL] [Abstract][Full Text] [Related]
6. Impurity profiling of ecstasy tablets seized in Hong Kong by gas chromatography-mass spectrometry.
Cheng JY; Chan MF; Chan TW; Hung MY
Forensic Sci Int; 2006 Oct; 162(1-3):87-94. PubMed ID: 16860955
[TBL] [Abstract][Full Text] [Related]
7. Profiling of 3,4-methylenedioxymethamphetamine by means of high-performance liquid chromatography.
Byrska B; Zuba D
Anal Bioanal Chem; 2008 Jan; 390(2):715-22. PubMed ID: 17994224
[TBL] [Abstract][Full Text] [Related]
8. Mixed-mode solid-phase extraction procedures for the determination of MDMA and metabolites in urine using LC-MS, LC-UV, or GC-NPD.
Jenkins KM; Young MS; Mallet CR; Elian AA
J Anal Toxicol; 2004; 28(1):50-8. PubMed ID: 14987425
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous analysis of amphetamine, methamphetamine, and 3, 4-methylenedioxymethamphetamine (MDMA) in urine samples by solid-phase extraction, derivatization, and gas chromatography/mass spectrometry.
Gan BK; Baugh D; Liu RH; Walia AS
J Forensic Sci; 1991 Sep; 36(5):1331-41. PubMed ID: 1955829
[TBL] [Abstract][Full Text] [Related]
10. Profiling of ecstasy tablets seized in iran.
Khajeamiri AR; Kobarfard F; Ahmadkhaniha R; Mostashari G
Iran J Pharm Res; 2011; 10(2):211-20. PubMed ID: 24250345
[TBL] [Abstract][Full Text] [Related]
11. A study of impurities in intermediates and 3,4-methylenedioxymethamphetamine (MDMA) samples produced via reductive amination routes.
Gimeno P; Besacier F; Bottex M; Dujourdy L; Chaudron-Thozet H
Forensic Sci Int; 2005 Dec; 155(2-3):141-57. PubMed ID: 16226151
[TBL] [Abstract][Full Text] [Related]
12. [Determination of amphetamines in human urine using microwave extraction-gas chromatography].
Wang J; Sun H; Ye N; Gu X; Li W; Li Y
Se Pu; 2008 Mar; 26(2):254-8. PubMed ID: 18581863
[TBL] [Abstract][Full Text] [Related]
13. Basic and neutral route specific impurities in MDMA prepared by different synthesis methods. Comparison of impurity profiles.
Swist M; Wilamowski J; Parczewski A
Forensic Sci Int; 2005 Dec; 155(2-3):100-11. PubMed ID: 16226147
[TBL] [Abstract][Full Text] [Related]
14. A review of recent advances in impurity profiling of illicit MDMA samples.
Waddell-Smith RJ
J Forensic Sci; 2007 Nov; 52(6):1297-304. PubMed ID: 17944907
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of the chemical profiles of 3,4-methylenedioxymethamphetamine based on comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry (GC × GC-TOFMS).
Schäffer M; Gröger T; Pütz M; Dieckmann S; Zimmermann R
J Forensic Sci; 2012 Sep; 57(5):1181-9. PubMed ID: 22509895
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and trends of 3,4-methylenedioxymethamphetamine (MDMA) tablets found in Taiwan from 2002 to February 2005.
Teng SF; Wu SC; Liu C; Li JH; Chien CS
Forensic Sci Int; 2006 Sep; 161(2-3):202-8. PubMed ID: 16842946
[TBL] [Abstract][Full Text] [Related]
17. Development of sample extraction and clean-up strategies for target and non-target analysis of environmental contaminants in biological matrices.
Baduel C; Mueller JF; Tsai H; Gomez Ramos MJ
J Chromatogr A; 2015 Dec; 1426():33-47. PubMed ID: 26643725
[TBL] [Abstract][Full Text] [Related]
18. Residual solvents in methylenedioxymethamphetamine tablets as a source of strategic information and as a tool for comparative analysis: the development and application of a static headspace gas chromatography/mass spectrometry method.
Visser HA; Visser-van Leeuwen M; Huizer H
Bull Narc; 2005; 57(1-2):167-82. PubMed ID: 21338020
[TBL] [Abstract][Full Text] [Related]
19. Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) synthesised from catechol.
Heather E; Shimmon R; McDonagh AM
Forensic Sci Int; 2015 Mar; 248():140-7. PubMed ID: 25617761
[TBL] [Abstract][Full Text] [Related]
20. 15N isotopic analyses: a powerful tool to establish links between seized 3,4-methylenedioxymethamphetamine (MDMA) tablets.
Palhol F; Lamoureux C; Naulet N
Anal Bioanal Chem; 2003 Jun; 376(4):486-90. PubMed ID: 12819848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
